Cochrane T, Enrico A, Gomez-Almaguer D, Hadjiev E, et al. Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy. Leuk Lymphoma 2023 Aug 25:1-4. doi: 10.1080/10428194.2023.2247511.
PMID: 37626019